There are 2789 resources available
206P - Disease behavior and treatment response of special histological types of triple-negative breast cancer
Presenter: Renata Bonadio
Session: ePoster Display
207P - Outcomes of patients with triple-negative breast cancer following neoadjuvant chemotherapy with anthracycline and taxane-based regimens plus carboplatin
Presenter: Bryan Vaca Cartagena
Session: ePoster Display
208P - ARB: Phase II window of opportunity study of preoperative treatment with enzalutamide in ER+ve and TNBC
Presenter: Peter Schmid
Session: ePoster Display
209P - Interim results of a phase I/Ib study of SBT6050 monotherapy and pembrolizumab combination in patients with advanced HER2-expressing or amplified solid tumors
Presenter: Samuel Klempner
Session: ePoster Display
210P - TACH101, a first-in-class KDM4 inhibitor for treatment of triple-negative breast cancer
Presenter: Frank Perabo
Session: ePoster Display
211P - Genetic and immunologic characteristics in Chinese breast patients with different HER2 mutation types
Presenter: Hui Cao
Session: ePoster Display
212P - HER2-low breast cancer: Evolution from primary tumor to residual disease after neoadjuvant treatment
Presenter: Federica Miglietta
Session: ePoster Display
213P - Predictive markers of cardiotoxicity associated with breast cancer treatment
Presenter: Ines Nogueira Costa
Session: ePoster Display
214P - Landscape of homologous recombination repair gene mutations in different molecular subtypes of breast cancer
Presenter: Yan Xu
Session: ePoster Display
215P - Somatic mutations and gene expression of neuroendocrine pathways in aggressive and nonaggressive breast cancer
Presenter: Kejia Hu
Session: ePoster Display